RxDoctor Payments Data

Sarah Satterfield, PA

Physician Assistant · Gainesville, GANPI 1649042680

Payments from drug & device makers

$3,058in general payments, 2019–2025

Across 132 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$678
  • Regeneron Healthcare Solutions, Inc.$382
  • Johnson & Johnson$355
  • Sanofi$306
  • Ardelyx, Inc.$213
  • Phathom Pharmaceuticals, Inc.$147
  • plus $978 from 12 others

What the payments were for

  • Food & beverage$2,97497%
  • Education$843%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,058 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$35,535
Medicare patients
324
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf129$20,837
LinzessLinaclotide23$13,248
SuprepSodium, Potassium,mag Sulfates40$4,570
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates57$3,729
Sucralfate32$1,776
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C12$1,689
Ondansetron OdtOndansetron305$1,010
Pantoprazole Sodium145$744
Omeprazole91$607
Dicyclomine Hcl16$404
Famotidine39$246

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$678$13,24823 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$114$1,68912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →